These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 27628523)

  • 1. 'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'.
    Lau MS; Mooney P; White W; Appleby V; Moreea S; Haythem I; Elias J; Bundhoo K; Corbett G; Wong L; Tsai HH; Cross S; Hebden J; Hoque S; Sanders D
    BMC Gastroenterol; 2016 Sep; 16():115. PubMed ID: 27628523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Random duodenal biopsy to exclude coeliac disease as a cause of anaemia is not cost-efective and should be replaced with universally performed pre-endoscopy serology in patients on a suspected cancer pathway.
    Herrod PJJ; Lund JN
    Tech Coloproctol; 2018 Feb; 22(2):121-124. PubMed ID: 29476446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coeliac disease detection with an IgA/IgG-deamidated gliadin peptide based point of care test in community pharmacies.
    Lau MS; Sanders DS
    Int J Clin Pharm; 2019 Apr; 41(2):583-588. PubMed ID: 30778740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Detection of Celiac Disease With Measurement of Deamidated Gliadin Peptide Antibody Before Endoscopy.
    Mooney PD; Wong SH; Johnston AJ; Kurien M; Avgerinos A; Sanders DS
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1278-1284.e1. PubMed ID: 25632807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Sensitivity of Simtomax Point of Care Test in Detection of Celiac Disease in a Prospective Multicenter Study.
    Tangermann P; Branchi F; Itzlinger A; Aschenbeck J; Schubert S; Maul J; Liceni T; Schröder A; Heller F; Spitz W; Möhler U; Graefe U; Radke M; Trenkel S; Schmitt M; Loddenkemper C; Preiß JC; Ullrich R; Daum S; Siegmund B; Bojarski C; Schumann M
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1780-1787.e5. PubMed ID: 30267867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.
    Hopper AD; Hadjivassiliou M; Hurlstone DP; Lobo AJ; McAlindon ME; Egner W; Wild G; Sanders DS
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):314-20. PubMed ID: 18328437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.
    Wolf J; Petroff D; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Kehler T; Flemming G; Schmidt F; Rodrigues A; Hasenclever D; Mothes T
    Gastroenterology; 2017 Aug; 153(2):410-419.e17. PubMed ID: 28461188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic yield of routine duodenal biopsies in iron deficiency anaemia: a study from Western Anatolia.
    Gonen C; Yilmaz N; Yalcin M; Simsek I; Gonen O
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):37-41. PubMed ID: 17206075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Screening for Celiac Disease, Deamidated Gliadin Rarely Predicts Disease When Tissue Transglutaminase Is Normal.
    Gould MJ; Brill H; Marcon MA; Munn NJ; Walsh CM
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):20-25. PubMed ID: 30052564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of routine duodenal biopsy in diagnosing coeliac disease in patients with iron deficiency anaemia.
    Mandal AK; Mehdi I; Munshi SK; Lo TC
    Postgrad Med J; 2004 Aug; 80(946):475-7. PubMed ID: 15299158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(21):1-111. PubMed ID: 23074399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum to: 'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'.
    Lau MS; Mooney PD; White WL; Appleby V; Moreea S; Haythem I; Elias JE; Bundhoo K; Corbett GD; Wong L; Tsai HH; Cross SS; Hebden JM; Hoque S; Sanders DS
    BMC Gastroenterol; 2016 Oct; 16(1):122. PubMed ID: 27716120
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of the anti-endomysial antibody test to diagnose coeliac disease in clinical practice.
    Pearce AB; Sinclair D; Duncan HD; Saas M; Poller DN
    Clin Lab; 2002; 48(5-6):319-25. PubMed ID: 12071583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease.
    Hoerter NA; Shannahan SE; Suarez J; Lewis SK; Green PHR; Leffler DA; Lebwohl B
    Dig Dis Sci; 2017 May; 62(5):1272-1276. PubMed ID: 28161854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of an IgA/IgG-Deamidated Gliadin Peptide Point-of-Care Test in Predicting Persistent Villous Atrophy in Patients With Celiac Disease on a Gluten-Free Diet.
    Lau MS; Mooney PD; White WL; Rees MA; Wong SH; Kurien M; Trott N; Leffler DA; Hadjivassiliou M; Sanders DS
    Am J Gastroenterol; 2017 Dec; 112(12):1859-1867. PubMed ID: 29016564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease.
    Niveloni S; Sugai E; Cabanne A; Vazquez H; Argonz J; Smecuol E; Moreno ML; Nachman F; Mazure R; Kogan Z; Gomez JC; Mauriño E; Bai JC
    Clin Chem; 2007 Dec; 53(12):2186-92. PubMed ID: 17901114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a point-of-care test based on deamidated gliadin peptides for celiac disease screening in a large pediatric population.
    Bienvenu F; Besson Duvanel C; Seignovert C; Rouzaire P; Lachaux A; Bienvenu J
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1418-23. PubMed ID: 23032795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point of care testing for paediatric coeliac disease in the new ESPGHAN era.
    Lau MSY; Sanders DS
    Rev Esp Enferm Dig; 2017 Nov; 109(11):741-742. PubMed ID: 29082741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.